Effect of a preoperative single-dose steroid on pulmonary function and postoperative symptoms after modified radical mastectomy: results of a randomized clinical trial
Author(s) -
Jorge Jiménez-Tornero,
Ana Olivia CortésFlores,
Mariana ChávezTostado,
Gilberto MorganVillela,
C. Zuloaga-Fernández del Valle,
R. Valle,
Luis Alberto García-González,
Vanesa Sarahí Fernández-Avalos,
Roberto Carlos Miranda-Ackerman,
Andrea Socorro Álvarez Villaseñor,
Gabriela AmbrizGonzález,
Francisco José BarbosaCamacho,
Clotilde FuentesOrozco,
Vianca Seleste Contreras-Cordero,
Alejandro GonzálezOjeda
Publication year - 2020
Publication title -
gland surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 22
eISSN - 2227-8575
pISSN - 2227-684X
DOI - 10.21037/gs-20-366
Subject(s) - medicine , nausea , vomiting , anesthesia , radical mastectomy , postoperative nausea and vomiting , breast cancer , surgery , dexamethasone , antiemetic , randomized controlled trial , modified radical mastectomy , placebo , mastectomy , pulmonary function testing , cancer , alternative medicine , pathology
Evidence suggests that a preoperative single-dose steroid improves lung function and decreases the incidence of postoperative symptoms; however, this has not been sufficiently proved in modified radical mastectomy for cancer. This study aimed to evaluate the efficacy of preoperative single-dose steroid administration for postoperative lung function and postoperative symptoms in women undergoing modified radical mastectomy for breast cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom